AGIO - Agios Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue94,38743,01169,89259,119
Cost of Revenue342,721292,681220,163141,827
Gross Profit-248,334-249,670-150,271-82,708
Operating Expenses
Research Development----
Selling General and Administrative114,14571,12450,71435,992
Non Recurring----
Others----
Total Operating Expenses456,866363,805270,877177,819
Operating Income or Loss-362,479-320,794-200,985-118,700
Income from Continuing Operations
Total Other Income/Expenses Net16,4516,1242,514968
Earnings Before Interest and Taxes-362,479-320,794-200,985-118,700
Interest Expense----
Income Before Tax-346,028-314,670-198,471-117,732
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-346,028-314,670-198,471-117,732
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-346,028-314,670-198,471-117,732
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-346,028-314,670-198,471-117,732